Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis.
about
Dealing with uncertainties in environmental burden of disease assessment.Pharmacological and psychosocial interventions for night eating syndrome in adultsMeasuring Functional and Patient-Reported Outcomes After Treatment of Mutilating Hand Injuries: A Global Health ApproachPulmonary impairment after tuberculosis and its contribution to TB burdenThe cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaCost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern MozambiqueDeterminants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenThe potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling studyCost-effectiveness of antivenoms for snakebite envenoming in NigeriaEconomic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancyImproving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, IndiaCost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda.The burden of human African trypanosomiasisDays lost due to disability of diclofenac-induced adverse drug reactions.Determining a cost effective intervention response to HIV/AIDS in Peru.Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of IndiaCost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets.Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh.Cost-effectiveness of "golden mustard" for treating vitamin A deficiency in IndiaCost and disease burden of dengue in CambodiaEstimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina.Cost-effectiveness of the "helping babies breathe" program in a missionary hospital in rural Tanzania.Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysisCost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.A multifaceted intervention to improve the quality of care of children in district hospitals in Kenya: a cost-effectiveness analysis.Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator.Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in Malawi.Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania.Weighting components of composite end points in clinical trials: an approach using disability-adjusted life-yearsAutomatic assessment of socioeconomic impact on cardiac rehabilitation.Burden of ischemic stroke in Korea: analysis of disability-adjusted life years lost.Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in UgandaManagement of chronic respiratory and allergic diseases in developing countries. Focus on sub-Saharan Africa.Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study.Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial.Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study.Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso.
P2860
Q21245805-4D85B81C-8AB0-4CD0-8165-BA5E7C89FE9CQ24186735-2C45EB78-ACD4-4BDB-A03E-80066A22DDE9Q28391419-336EB968-32C1-4E17-843E-9AEE93266523Q28396542-020624DD-7BD4-401D-A485-A72A4D717D8EQ28474404-A856BE4F-8EDA-4C0D-BCE2-A5408E3A2762Q28475795-ADDAFDA8-7EA1-4F6B-AF93-769D72D7807EQ28477679-6ED00D89-A995-425C-BDA2-B95D2A8B4F90Q28484308-CAA039D3-0D61-4FD8-97E8-EDAA7C358B5AQ28542985-8387B2EF-19FE-4043-9FB4-D2872AF1D0C4Q28546725-A2C90228-4E0B-40CA-A877-BBFD70BB4201Q30062123-78AC0428-BE82-428B-A2D7-CBA81C3A2716Q30480165-A3B7DCA9-315F-4E7A-B8D0-45927A4A7032Q33286065-2219FA83-AE28-4BFA-BC73-F7A6EC35183CQ33325763-7E5D9A33-213A-496A-9689-29DCD27742C2Q33395338-4D9EE261-1CA4-457A-AC83-35DA9A72D49DQ33459592-F2E20C27-411C-4AB9-A34E-D48F6ECF8E57Q33504903-3EA0E14B-79E9-454A-9EFF-EB2E6DB5CC68Q33575387-C22CB2E1-5718-43B5-9A3E-A31ED8DC06E0Q33590453-8495BC0B-4F28-4E20-A012-2006C9C05609Q33606843-CBEDF874-D484-4E2D-B36F-BA6053604575Q33623123-E2B49191-1BF7-4065-8CB3-376F6BF48145Q33656508-EB2F210E-C051-4357-A844-C9B180F76A56Q33679316-DD1A5819-241F-46F7-9207-87C379E1BC1AQ33723567-7D139627-52A6-4E6B-933F-3CE038039451Q33875425-B54C9376-0CBE-4D74-8A5C-6A2888B1A897Q34118097-B0073F27-EB52-40DA-813C-BF6014A36EC3Q34227179-17F8417D-DB01-4334-B259-E199B7A0E556Q34311513-C1B50BF4-C366-4E20-A2E8-D94FCFC2A984Q34640244-BE6185F5-4FC8-4A43-A30E-3D327809DA04Q34647897-53D4628F-6380-469C-8DC4-39E3D68D5D19Q34960038-4ABE6E81-2E5E-4873-A628-0DD8CD1B5D32Q35029327-A433A06F-8787-48F0-9CF5-4D40BF09D8D6Q35055779-89591D25-B6F0-48EF-BC51-CCC6A3C2EFDFQ35091676-7B1DC677-FC02-45EC-865C-FA897DC3253EQ35097828-1C1C4FB2-DD9A-4ED8-9CD4-2A7A91752D37Q35112404-D8CFF661-E733-4107-9290-86BFCFB80B89Q35223014-BC3AABFC-96BE-4CE4-BAD1-1510957132ABQ35329782-6F8AA4C4-411E-487B-9759-416E6F60CB08Q35354490-7DA11D7F-EBEB-4B1A-81F4-60D92246A118Q35428651-63264AA9-2FBA-4A03-BE68-57BEB4E4FBC2
P2860
Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Calculating and presenting dis ...... n cost-effectiveness analysis.
@en
Calculating and presenting disability adjusted life years
@nl
type
label
Calculating and presenting dis ...... n cost-effectiveness analysis.
@en
Calculating and presenting disability adjusted life years
@nl
prefLabel
Calculating and presenting dis ...... n cost-effectiveness analysis.
@en
Calculating and presenting disability adjusted life years
@nl
P356
P1476
Calculating and presenting dis ...... in cost-effectiveness analysis
@en
P2093
P304
P356
10.1093/HEAPOL/16.3.326
P577
2001-09-01T00:00:00Z